Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Stereotactic Radiotherapy With Different Fractionation Modes for Early Lung Cancer

NCT05802641 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05802641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Stereotactic Radiotherapy With Different Fractionation Modes for Early Lung Cancer
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 7, 2018
Completion date
January 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fractionation, lung cancer, radiotherapy, stereotactic body radiotherapy